标题 |
[高分] 专利、报告等 709679-lbl-047-an-afucosylated-anti-bdca2-taci-fusion-protein-with-extended-half-life-and-dual-immunosuppressive-functions
具有延长半衰期和双重免疫抑制功能的融合蛋白
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
Immune LBL-047, an afucosylated anti-BDCA2/TACI fusion protein with extended half-life and dual immunosuppressive functions June 19, 2024 At the recent EULAR meeting, a presentation by Nanjing Leads Biolabs Co. Ltd. covered the discovery of LBL-047, a novel bifunctional fusion protein targeting both plasmacytoid dendritic cells (pDCs) and B cells; it is being developed for the treatment of autoimmune diseases. BioWorld ScienceConferencesImmuneProtein |
求助人 | |
下载 |